Written and maintained by CASRAI Editorial Board
Last updated
A teledermatology platform is a specialized clinical imaging and virtual consultation software system designed to capture, calibrate, transmit, and evaluate macroscopic skin photographs and magnified epiluminescence (dermoscopy) images for remote dermatologic diagnosis, primary-to-specialty eConsult triage, and clinical trial central endpoint adjudication.
What Is Teledermatology?
Teledermatology is the subspecialty of telemedicine that applies telecommunication and biomedical imaging technologies to diagnose and manage cutaneous, hair, and nail disorders across a distance. Because dermatology is fundamentally a visual morphological discipline, general-purpose video-conferencing tools often fail in dermatologic care: standard real-time WebRTC video streams compress resolution and frame rates when bandwidth fluctuates, washing out subtle erythema, pigment network asymmetry, scale, and vascular patterns.
According to the American Academy of Dermatology (AAD) and American Telemedicine Association (ATA) Practice Guidelines for Teledermatology, clinical teledermatology platforms operate across three primary delivery architectures:
| Teledermatology Model | Technical & Clinical Workflow | Diagnostic Image Fidelity | Primary Use Cases & CPT Coding |
|---|---|---|---|
| 1. Store-and-Forward (Asynchronous / SAF) | Referring PCP, medical assistant, or patient captures uncompressed/lossless macro photos and dermoscopic images paired with a structured lesion history; dermatologist reviews asynchronously in a reading queue. | Highest (12–48 MP still capture + polarized/non-polarized teledermoscopy attachment). | Primary care eConsults (CPT 99451/99452 via platforms like AristaMD or ConferMED), VA/DoD skin cancer triage, and HCPCS G2010. |
| 2. Live Interactive (Synchronous Video) | Real-time two-way WebRTC audio-video visit between patient and dermatologist. | Low to Moderate (dependent on patient lighting, camera focus, and video codec compression). | Isotretinoin / biologic follow-up monitoring, medication counseling, and post-treatment symptom checks (CPT 99202–99215 with Modifier 95). |
| 3. Hybrid Teledermatology | Combines mandatory pre-visit store-and-forward high-resolution image upload with a scheduled live audio-video or telephone discussion. | High (combines static macro/dermoscopic resolution with live history clarification and counseling). | Complex inflammatory dermatoses (psoriasis, atopic dermatitis, hidradenitis suppurativa) and direct-to-patient virtual dermatology clinics. |
Core Technical Capabilities of an Enterprise Teledermatology Platform
Unlike generic telehealth software, a dedicated teledermatology platform (such as DermEngine / MetaOptima, Klara Teledermatology, VisualDx / DermExpert, or VA Teledermatology Reader apps) incorporates specialized optical, metadata, and interoperability engineering:
- 1. Smartphone Teledermoscopy Hardware Integration: For pigmented skin lesions (screening for melanoma, basal cell carcinoma, and squamous cell carcinoma), macroscopic photography alone is insufficient. Teledermatology platforms pair mobile capture apps with clip-on optical dermatoscopes (offering $10times$ to $20times$ magnification with cross-polarized and non-polarized LED illumination). Cross-polarized light eliminates surface skin glare (stratum corneum reflectance) to visualize deep dermal pigment networks, blue-white veils, and arborizing vessels, while non-polarized contact dermoscopy highlights superficial milia-like cysts and comedo-like openings.
- 2. Anatomical 3D Body Mapping & Serial Lesion Tracking (Total Body Photography): Platforms provide an interactive 2D/3D anatomical body mannequin (mapped to SNOMED CT anatomical site codes) where each photographed lesion is pinned by exact body location. During longitudinal mole mapping in high-risk dysplastic nevus syndrome or melanoma patients, side-by-side temporal registration overlays baseline and follow-up dermoscopic images to quantify diameter expansion, color shifts, or border evolution.
- 3. DICOM WG-19 Standards (Supplement 221 Dermoscopy & Supplement 237): To prevent dermatology images from sitting in proprietary vendor silos outside the hospital Picture Archiving and Communication System (PACS) or Vendor Neutral Archive (VNA), the DICOM Standards Committee Working Group 19 (WG-19, Dermatology) established DICOM Supplement 221 (Dermoscopy) and Supplement 237 (Total Body Photography). A standards-compliant teledermatology platform encapsulates visible-light and dermoscopic JPEG/PNG captures into DICOM objects containing standardized tags for lens magnification, polarization mode, immersion medium, millimeter ruler scale, and International Color Consortium (ICC) color profiles, and exposes HL7 FHIR R4
ImagingStudy,Media/DocumentReference, andDiagnosticReportresources. - 4. Edge AI Image Quality & Triage Decision Support: Integrating AI in telemedicine, client-side computer vision models verify image focus, lighting exposure, and scale calibration at the moment of capture, rejecting blurry uploads immediately. For clinician decision support, convolutional neural networks (CNNs) and vision transformers retrieve visually similar reference pathology cases or stratify lesion malignancy risk prior to biopsy referral.
How Teledermatology Platforms Are Used in Clinical Research and Decentralized Trials
In pharmaceutical and medical device research, teledermatology platforms serve as regulated imaging infrastructure for Phase II–IV dermatology clinical trials (evaluating biologics, JAK inhibitors, and topical agents in plaque psoriasis, atopic dermatitis, alopecia areata, vitiligo, and acne vulgaris):
- Centralized Blinded Rater Adjudication (Reducing Site Rater Variance): Traditional dermatology trials suffer from high inter-rater variability across clinical trial sites when local investigators score subjective severity scales—such as the Psoriasis Area and Severity Index (PASI), Eczema Area and Severity Index (EASI), Investigator’s Global Assessment (IGA), or Severity of Alopecia Tool (SALT). Using a 21 CFR Part 11-compliant teledermatology platform, site staff or home-based participants capture standardized photographs using color-calibration cards (Macbeth ColorChecker) and fixed focal distances; a central panel of blinded board-certified dermatologists then scores every image consistently, reducing placebo response inflation and increasing statistical power.
- Pairing Cutaneous Imaging with ePRO Diaries: In Decentralized Clinical Trials (DCTs), remote lesion photography is synchronized with daily electronic Clinical Outcome Assessment (eCOA) patient diaries—such as the Peak Pruritus Numerical Rating Scale (PP-NRS), Dermatology Life Quality Index (DLQI), and Patient-Oriented Eczema Measure (POEM)—providing regulators with correlated objective morphological clearance and patient-reported symptom relief.
Frequently Asked Questions
What is teledermatology?
Teledermatology is the practice of remote dermatologic medicine using digital photography, smartphone-attached dermatoscopes (teledermoscopy), and video telecommunications. It is delivered through three primary models: asynchronous Store-and-Forward (SAF) image evaluation, synchronous live interactive video visits, and hybrid consultations that combine pre-visit high-resolution image uploads with a live clinician discussion.
What makes a teledermatology platform different from a standard telehealth video platform?
Unlike general WebRTC video platforms whose compressed video streams blur fine skin detail, a dedicated teledermatology platform captures uncompressed macroscopic and polarized/non-polarized dermoscopic images, pins lesions to a 3D SNOMED CT anatomical body map for longitudinal tracking, embeds millimeter scale and ICC color calibration metadata, and archives images to hospital PACS/VNAs using DICOM WG-19 (Supplement 221 Dermoscopy) and HL7 FHIR R4 imaging standards.
